Presentation highlights death of 34-year-old after Covid vaccine, lack of autopsies, and critical aspects of pandemic. • 0:12 Importance of supporting voices questioning vaccine safety and challenging the science behind it. • 2:34 Mother's frustration with CDC's...

Whistleblowing comes with significant costs and challenges. • 0:35 Leaked vaccination data raised concerns about patient confidentiality and data protection. • 1:20 The speaker feels a responsibility to address Covid-19 issues due to their research on autoimmunity. •...

Discussion on the importance of Plan B in the current global COVID-19 situation. • 1:09 Scott Freeman's background in cancer biology and interest in COVID-19. • 1:49 Dr. Christopher Ring's expertise in diagnostic virology and antiviral drug development. • 3:01 The...

Steroids, particularly prednisone, played a crucial role in managing severe COVID-19 cases. • 0:04 The drug was widely used by healthcare professionals to prevent deaths in serious COVID-19 patients. • 1:03 A research breakthrough in June 2020 highlighted the...

World Health Organization has limited knowledge about the Omicron variant, including transmissibility and severity. • 0:40 Preliminary data suggests increased rates of hospitalizations in South Africa and potential risk of reinfection for those previously infected. •...

Dr. Philip McMillan discusses the inevitability of an Omicron lockdow. • 0:05 Research in Sheffield on Omicron infection post-vaccination and immune response. • 0:55 Upcoming conference on post-vax/long covid for understanding pandemic challenge. • 1:34 Lack of clear...

Dr. Philip McMillan reviews top videos on COVID-19 and autoimmune diseases. • 0:05 Focus on reinfections leading to autoimmune responses and severe disease. • 1:57 Discussion on natural immunity and vaccine decisions during the pandemic. • 3:21 Importance of research...

Data set covers period from April 2021 to December 2022, including various vaccination cohorts. • 2:38 Data released on February 21, 2023, under pressure from NP Andrew Bridge. • 2:47 Objective analysis needed to determine benefits and risks for both vaccinated and...

Introduction to the complexities of mRNA technology and the need to address unknown unknowns. • 0:03 Discussion on the importance of pseudo urines in bypassing the immune system for vaccine effectiveness. • 1:24 Explanation of the challenges faced in getting mRNA...